BUSINESS
Gland Pharma Gains as USFDA Completes Pre-Approval Inspection at Visakhapatnam Facility
Gland Pharma’s stock surged on the BSE, following the successful conclusion of a Pre-Approval Inspection (PAI) by the United States Food and Drug Administration (USFDA) at its Visakhapatnam…